A. Brisuda

4.2k total citations
20 papers, 393 citations indexed

About

A. Brisuda is a scholar working on Surgery, Urology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, A. Brisuda has authored 20 papers receiving a total of 393 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Surgery, 6 papers in Urology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in A. Brisuda's work include Bladder and Urothelial Cancer Treatments (15 papers), Urinary and Genital Oncology Studies (8 papers) and Urological Disorders and Treatments (6 papers). A. Brisuda is often cited by papers focused on Bladder and Urothelial Cancer Treatments (15 papers), Urinary and Genital Oncology Studies (8 papers) and Urological Disorders and Treatments (6 papers). A. Brisuda collaborates with scholars based in Czechia, United States and France. A. Brisuda's co-authors include Marek Babjuk, Pierre I. Karakiewicz, Yair Lotan, Marc Zerbib, Évanguelos Xylinas, Michael Rink, Yves Fradet, Shahrokh F. Shariat, Douglas S. Scherr and Luis A. Kluth and has published in prestigious journals such as PLoS ONE, European Journal of Cancer and Advances in experimental medicine and biology.

In The Last Decade

A. Brisuda

16 papers receiving 388 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Brisuda Czechia 8 229 150 116 95 72 20 393
Lauren Shuman United States 10 355 1.6× 217 1.4× 127 1.1× 76 0.8× 34 0.5× 16 491
Kirstin A. van der Keur Netherlands 6 329 1.4× 176 1.2× 81 0.7× 59 0.6× 63 0.9× 7 388
Kim E.M. van Kessel Netherlands 12 333 1.5× 202 1.3× 99 0.9× 89 0.9× 46 0.6× 18 459
Shahin Chandrasoma United States 8 290 1.3× 262 1.7× 97 0.8× 34 0.4× 74 1.0× 13 452
Quoc Cuong Tran Australia 5 185 0.8× 134 0.9× 53 0.5× 31 0.3× 16 0.2× 6 290
David Darling New Zealand 7 274 1.2× 75 0.5× 54 0.5× 28 0.3× 67 0.9× 12 293
Akinori Minato Japan 11 203 0.9× 48 0.3× 120 1.0× 20 0.2× 29 0.4× 48 339
Victoria Hinder New Zealand 7 136 0.6× 67 0.4× 64 0.6× 26 0.3× 31 0.4× 18 264
Květoslava Pecková Czechia 11 78 0.3× 180 1.2× 227 2.0× 88 0.9× 8 0.1× 20 271
Benjamin Miron United States 8 131 0.6× 81 0.5× 160 1.4× 43 0.5× 19 0.3× 23 277

Countries citing papers authored by A. Brisuda

Since Specialization
Citations

This map shows the geographic impact of A. Brisuda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Brisuda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Brisuda more than expected).

Fields of papers citing papers by A. Brisuda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Brisuda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Brisuda. The network helps show where A. Brisuda may publish in the future.

Co-authorship network of co-authors of A. Brisuda

This figure shows the co-authorship network connecting the top 25 collaborators of A. Brisuda. A scholar is included among the top collaborators of A. Brisuda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Brisuda. A. Brisuda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Haq, Farhan, Jaromír Háček, A. Brisuda, et al.. (2024). Clinical and molecular response to alpha1‐oleate treatment in patients with bladder cancer. Cancer Medicine. 13(17). e70149–e70149. 1 indexed citations
2.
Ambite, Inès, A. Brisuda, Jaromír Háček, et al.. (2024). Similar immune responses to alpha1‐oleate and Bacillus Calmette–Guérin treatment in patients with bladder cancer. Cancer Medicine. 13(7). e7091–e7091. 2 indexed citations
4.
Brisuda, A., et al.. (2023). Transurethral resection of bladder cancer with or without fluorescence. Current Opinion in Urology. 33(2). 152–156.
5.
Háček, Jaromír, A. Brisuda, Marek Babjuk, & Josef Zámečnı́k. (2020). Expression of cancer stem cells markers in urinary bladder urothelial carcinoma and its precursor lesions. Biomedical Papers. 165(3). 316–321. 7 indexed citations
6.
Roumiguié, M., Évanguelos Xylinas, A. Brisuda, et al.. (2020). Consensus Definition and Prediction of Complexity in Transurethral Resection or Bladder Endoscopic Dissection of Bladder Tumours. Cancers. 12(10). 3063–3063. 5 indexed citations
7.
Kotaška, Karel, M. Polák, A. Brisuda, & Richard Průša. (2020). Polycyanoacrylate (super glue) as bladder concretion in a patient after bilateral inguinal hernioplasty. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 57(4). 328–331. 2 indexed citations
10.
Brisuda, A., et al.. (2017). Intravesical thermotherapy with Mitomycin C in patients with non-muscle-invasive bladder cancer – single site results. European Urology Supplements. 16(11). e2942–e2942.
11.
Hořínek, Aleš, A. Brisuda, Iveta Svobodová, et al.. (2016). MicroRNAs in urine supernatant as potential non-invasive markers for bladder cancer detection. Neoplasma. 63(5). 799–808. 48 indexed citations
12.
Svobodová, Iveta, Aleš Hořínek, A. Brisuda, et al.. (2016). Comparison of MicroRNA Content in Plasma and Urine Indicates the Existence of a Transrenal Passage of Selected MicroRNAs. Advances in experimental medicine and biology. 924. 97–100. 7 indexed citations
13.
Brisuda, A., Viktor Soukup, Aleš Hořínek, et al.. (2015). Urinary Cell-Free DNA Quantification as Non-Invasive Biomarker in Patients with Bladder Cancer. Urologia Internationalis. 96(1). 25–31. 38 indexed citations
15.
Poletajew, Sławomir, et al.. (2014). Timing of radical cystectomy in Central Europe – multicenter study on factors influencing the time from diagnosis to radical treatment of bladder cancer patients. Editor-in-Chief s Voice List of Authors is an Important Element in a Scientific Publication. 5 indexed citations
17.
Wozniak, Magdalena B., Florence Le Calvez‐Kelm, Behnoush Abedi‐Ardekani, et al.. (2013). Integrative Genome-Wide Gene Expression Profiling of Clear Cell Renal Cell Carcinoma in Czech Republic and in the United States. PLoS ONE. 8(3). e57886–e57886. 104 indexed citations
18.
Xylinas, Évanguelos, Michael Rink, Brian D. Robinson, et al.. (2013). Impact of histological variants on oncological outcomes of patients with urothelial carcinoma of the bladder treated with radical cystectomy. European Journal of Cancer. 49(8). 1889–1897. 130 indexed citations
19.
Rink, Michael, Luis Kluth, Yair Lotan, et al.. (2013). 276 Impact of histological variants on oncological outcomes of patients with urothelial carcinoma of the bladder treated with radical cystectomy. European Urology Supplements. 12(1). e276–e277. 19 indexed citations
20.
Büchler, Tomáš, et al.. (2012). Positron emission tomography and clinical predictors of survival in primary extragonadal germ cell tumors.. PubMed. 25(3). 178–83. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026